FIFTH COMMUNITY PHARMACY AGREEMENT CONSULTATION
FIFTH COMMUNITY PHARMACY AGREEMENT: OVERVIEW OF STAKEHOLDER CONSULTATION ACTIVITIES TO
30 JUNE 2014
5CPA component
Consultation activity
With whom
Timeframe
Action taken in response
5CPA programmes

Consumer views on the services
and advice provided by
pharmacies to consumers;
The location of pharmacies;
Issues relevant to competition
between pharmacies; and
Increased accountability of
pharmacy owners for the
professional pharmacy services
provided to consumers.

CHF
December 2009 –
December 2010

Advice provided informed policy options and
negotiations for 5CPA.
Advice sought on patient eligibility for
the MedsCheck and Diabetes
MedsCheck pilots

PRG
December 2010 –
June 2012

Inclusion of ‘improved adherence’ to the aims of
the programme.
Use of broad patient eligibility criteria initially for
the pilot that could be refined to inform the
national roll-out.
Added ‘significant medical event and
complexity/type of administration’ as an
additional indicator to number of drugs included.
The interim evaluation report was provided to
the PRG on 1 February 2012 for comment.
Further consultation may be undertaken
following finalisation of the evaluation in
April 2012.



Medication Use
Reviews (MedsCheck)
and Diabetes
Medication
Management Service
(Diabetes MedsCheck)



Two stage testing functionality of the
Assessment Tool




PSA
AACP
Guild
Practising Community
Pharmacists
June 2011 and July
2011

Feedback incorporated into Assessment Tool.
Consultation on community pharmacy
software requirements

MSIA
Finalised mid 2012

Developing vendor resource documents to
inform possible open source software solutions
linking dispense and claiming functions of the
planned system.
Current as at 30 June 2014
5CPA component
Consultation activity
With whom
Timeframe
Action taken in response
Home Medicines
Review (HMR)
Development of new direct referral
pathway to HMR




PSA
Guild
AACP
Other stakeholder
consultations under
4CPA HMR research
project
December 2008 –
October 2011





December 2008 –
Ongoing






PRG
Guild
AACP
State and Territory
health departments
RACP
APHA
ACSQHC
SHPA
AGPN
Public consultation
HMR (and other MMR programmes)
changes

PRG
April 2013- ongoing

Provide advice to inform options to restructure
the HMR (and other MMR Programmes fee
structure) to support programme sustainability
and integrity.
HMR research project to collate and
assess evidence in order to
recommend better targeting of HMR
patient eligibility criteria




SHPA
PSA
Guild
PRG
March 2013 –
ongoing


Joint involvement in development of RFT
Ongoing input into project outcomes.
Development of requirement for
RMMR services to be collaborative
(referred by a general practitioner)



PSA
Guild
Other stakeholder
consultations under
4CPA RMMR
research project
May 2010 –
October 2011

The change to require all reviews to be
collaborative was implemented on
1 October 2011.
Home Medicines
Review (HMR)
Residential Medication
Management Review
(RMMR)
Development a hospital referral
pathway for HMRs.
HMR hospital referral pathway
stakeholder consultation workshop
29 June 2012
2





Implementation of a new direct referral pathway
to HMR from 1 October 2011.
Update of existing professional practice
guidelines to incorporate the new referral
pathway by PSA.
A consultation paper was released on
9 December 2011 and submissions closed on
20 January 2012. This paper was developed
with input from PRG, and 75 submissions were
received.
Summary of the consultation responses
provided to PRG for information on
19 April 2012.
Further stakeholder consultations will be
undertaken prior to finalisation of a HMR
Hospital Referral Pathway.
. Two hospitals selected (in Hobart and
Melbourne) with the Department ready to
commence, pending agreement on a
commencement date with the Guild. A
staggered national implementation is planned,
which will be informed by data from the two
initial sites.
Current as at 30 June 2014
5CPA component
Rural Pharmacy
Workforce
Rural Pharmacy
Maintenance
Allowance
Consultation activity
With whom
Timeframe
Action taken in response
Development of policy changes to
separate RMMR services from Quality
Use of Medicines services.



May 2010 –
October 2011

PSA
Guild
Other stakeholder
consultations under
4CPA RMMR
research project

Splitting payments for RMMR and QUM
services from 1 October 2011.
Update of the existing professional practice
guidelines to incorporate changes to the RMMR
programme.

Provide feedback as it arises.

Consultation with AHREN, PSA and PRG
undertaken.
Changes resulting from update to PhARIA
classification implemented in July 2012.
Exceptional circumstance criteria under
development by Guild for
1) Rural and Remote Continuing Education
Allowance
2) Rural Intern Training Allowance
3) Intern Incentive Allowance for Rural
Pharmacies.
4) Rural Student Placement Allowance.
August 2012
PRG members asked to seek views
from their members/organisations
regarding unforeseen impacts from
1 October 2011 changes to RMMR
programme

PRG
Eligibility changes to a number of
elements of RPWP resulting from
PhARIA update and restrictions to
PhARIA 2-6




ARHEN
PSA
Guild
Pharmacy academics
from various
universities
2011 – Ongoing
Advice on programme implementation,
transitional arrangements and
exceptions for the Rural Pharmacy
Continuing Professional Education
Allowance and the Rural Pharmacy
Student Placement Allowance

PRG
December 2011 –
January 2012
Development of an updated model, in
the context of a changing rural index







Guild
DHS
University of Adelaide
3
Late 2010 – July
2012


Consultation undertaken over mid 2011 January 2012.
Advice provided to PRG on 19 April 2012
regarding changes to RPWP.
Implementation complete and pharmacy owners
advised where RPMA eligibility has not
continued.
An exceptional circumstance process is being
managed by the Guild.
Current as at 30 June 2014
5CPA component
Consultation activity
With whom
Timeframe
Action taken in response
Section 100 Support
Allowances to Remote
Area Aboriginal Health
Services (AHS)
Consultation on potential changes to
programme arrangements



PRG
Guild
Other stakeholder
consultations under
4CPA evaluation of
Indigenous pharmacy
programmes
Over 250 attendees at
the Indigenous Joint
Forum
2010-11 –
Ongoing


QUM Framework to
support rural and
urban Aboriginal
Health Services

Indigenous Joint Forum held in Melbourne on
26/27 March 2012 provided opportunities for
further consultation with all delegates (over 250
delegates attended).
Joint Forum outcomes have been collated,
consolidated and considered by QUMAX
Reference Group and the 5CPA PRG. No final
decisions regarding programme changes have
been made.
Consultation on the recommendations
from the Senate inquiry into the supply
arrangements of PBS medicines to
remote area AHSs (which included
consideration of support
arrangements)

PRG
November 2011 ongoing

Government is in the process of finalising its
response to the Senate inquiry
recommendations.
Consultation on potential changes to
programme arrangements



PRG
Guild
Other stakeholder
consultations under
4CPA evaluation of
QUMAX programme
Over 250 attendees at
the Indigenous Joint
Forum
2010-11 –
Ongoing

Updated programme arrangements have been
implemented.
Indigenous Joint Forum held in Melbourne on
26/27 March 2012 provided opportunities for
further consultation with all delegates (over 250
delegates attended).
Joint Forum outcomes have been collated,
consolidated and considered by QUMAX
Reference Group and the 5CPA PRG.
Taking into account the findings from
the 4CPA evaluation of QUMAX,
consultation on changes to the
QUMAX programme
QUMAX Programme
Reference Group, made
up of:

DoHA

Guild

NACCHO

PSA


Ongoing




4
The new QUMAX programme model has been
developed in the context of input from all
stakeholders and implemented.
QRG met on 14 February 2012 and
8 March 2012 to discuss QUMSP and NACCHO
State Affiliate support arrangements post
30 June 2012.
QRG met on 22 June 2012 – QUMSP and
NACCHO State Affiliate support arrangements
extended to 31 December 2012.
From 1 Jan 2013, online education and training
resources are being implemented to assist
participating Aboriginal Health Services with
their application, workplan and reporting
requirements. Further assistance will also be
available through Guild and NACCHO telephone
hotlines.
Current as at 30 June 2014
5CPA component
Consultation activity
With whom
Timeframe
Action taken in response
Pharmacy Practice
Incentive (PPI) and
Accreditation

PPI: Clinical
Interventions by
Pharmacists
Consultation regarding priorities for
programme funding under 5CPA
Broad stakeholder input
through PPSAC 4CPA
Research & Development
Steering Committee and
4CPA Research &
Development project
(PROMISe).
October 2008 –
May 2010

Inclusion of Clinical Interventions as a priority
programme area in 5CPA.
Activities to support the roll-out of the
PPI Programme under 5CPA
PSA, with Expert
Reference Group
involvement, including
Guild, SHPA, APESMA,
ACP, APC, AACP, PDL,
CHF, RACGP, AGPN,
AMA, NPS, Carers Aust,
ASMI
September 2010 2011

Development of Professional Standards and
Guidelines and online educational resources by
PSA.

PPI: Support for the
Provision of Dose
Administration Aids
Consultation about the evaluation of
the 4CPA DAA/PMP Programme

Broad stakeholder
input under 4CPA
DAA/PMP evaluation.
September 2007 –
June 2009

Inclusion of a DAA component in the 5CPA.

PPI: Staged supply
support allowance
Consultation about the 4CPA review of
Staged Supply regarding implications
for community pharmacies in the
administration of Staged Supply of
PBS medicines.



AMA
CHF
State and territory
health departments
SHPA
ANCD
diverse range of other
stakeholders
February 2010 –
2011

Inclusion of Staged Supply component in 5CPA.
Consultation on activities to support
the roll-out of the PPI Programme
under 5CPA

PSA with Expert
Reference Group
involvement.
September 2010 –
2011

Development of professional Standards and
Guidelines and online educational resources by
PSA.



5
Current as at 30 June 2014
5CPA component
Consultation activity
With whom
Timeframe
Action taken in response

Development of a Community
Pharmacy Service Charter























December 2010 –
June 2011

PPI: Funding to
support the
Accreditation
System and roll-out
of Additional
Programmes to
Support Patient
Services
ACSA
AHPA
APESMA
AACP
AGPN
AHPRA
AHRC
AMA
ANF
ASMI
Carers Australia
CHF
Council of the Ageing
NACCHO
NAPSA
NEDA
NPS
NRHA
PSA
PBA
SHPA
ACSQHC
Guild
6


Convened a workshop in December 2010 to
discuss how to tailor the Australian Charter of
Healthcare Rights to be suitable for a
community pharmacy setting.
Draft concepts for the Community Pharmacy
Charter were developed and distributed for
wider consultation and comment.
The Community Pharmacy Service Charter was
finalised and implemented in June 2011.
Current as at 30 June 2014
5CPA component
Consultation activity
With whom
Timeframe
Action taken in response
Research and
Development
Workshop to inform 5CPA research
priorities and identify a list of potential
projects for research focus under the
5CPA
Approximately 175
participants attended a
workshop representing a
wide range of
stakeholders that included:
professional and industry
organisations,
government, peak bodies
and consumers.
The Advisory Panels
comprise representatives
from the following
organisations:

PSA

CHF

ASMI

SHPA

AACP

AMA

RACGP

Illuminate Health
Consulting

NRHA

Health Consumers of
Rural & Remote
Australia

PBA

The George Institute
for Global Health

NMHCCF
March 2010 and
April 2011
A number of research priority areas were
recommended, including six that were subsequently
funded under the 5CPA programme:

Mental Health

Professional Integration (Collaboration)

Rural

Health Literacy

Consumer Needs

Chronic Illness
The Rural project has subsequently been
discontinued.
Inclusion of a further Research and
Development project on HMR Patient
Eligibility

Guild
March 2013 October 2013

Commencement in October 2013 of HMR
Patient Eligibility project.
Review of the Existing Supply
Arrangements of PBS Medicines
in Residential Aged Care
Facilities and Private Hospitals under
4CPA





Aged care sector
Private hospitals
Medical practitioners
Nurses
Pharmacists
Residents and
patients
September 2009

Inclusion of ‘Medication Charts’ initiative in
5CPA.
Informing policy parameters of initiative.
Initiative Development Meetings




Guild
DHS
OACQC
ACSQHC
August 2010 –
October 2012
Supply and PBS
claiming from a
medication chart in
Residential Aged Care
Facilities
Establishment of Advisory Panels to oversee the
research projects.
Advisory panels select tenders and provide advice
and guidance on the individual research projects.




7
Development of a public consultation paper.
Identification and resolution of policy issues in
relation to programme design and
implementation.
Agreement on elements of the programme that
required broader consultation.
Current as at 30 June 2014
5CPA component
Consultation activity
With whom
Timeframe
Action taken in response
Supply and PBS
claiming from a
medication chart in
Residential Aged Care
Facilities
Draft content of consultation paper for
comment


PRG
AMA
November –
December 2010
Changes were made to the draft public consultation
papers as a result of PRG advice including:

increased emphasis on the reduced
administrative burden for the pharmacist;

ensured consistent use of the term “prescriber”,
as opposed to medical practitioner or doctor;
 included further information on the link with
QUM policy and the Authority medicines
process.
Call for responses on parameters of
the initiative through the release of a
consultation paper


PRG
Targeted aged care
stakeholders
Broad range of
pharmacy and
prescribing industry
stakeholders
State and territory
health authorities
The general public
March 2011 –
April 2011

Aged care facilities
Public and private
hospitals
Community
pharmacies
Medication packaging
companies
November 2010 –
June 2011

Inform legislative amendments to the National
Health Act 1953, identify policy issues and
potential change management issues.
AMA
November 2010,
June 2011, January
2012 and
April 2012

Resolved the issue about how ‘repeat’
medication orders will be dealt with on the chart
Informed communication requirements for
prescribers.
February, August,
November,
December 2011
and March 2012.




Site visits to inform policy and
implementation issues




Discussions with the AMA to identify
issues for prescribers
Meetings with representatives from
state and territory departments of
health

All jurisdictions




Consultation on community pharmacy
software requirements


May 2011 to
December 2012
MSIA
ACIVA
8

Responses informed legislative amendments
currently before parliament.
Highlighted the importance of safety and quality
use of medicines requirements which have
resulted in the Department engaging the
ACSQHC to develop the National Residential
Medication chart.
Informed issues to be address in relation to
implementation and change management
activities.
Identified and incorporated key issues into the
development and implementation of the
initiative, including informing legislative
amendments.
Provided information in relation to
Commonwealth legislative and regulatory
changes.
Identified requirements for software vendors to
support the transition to new arrangements.
Current as at 30 June 2014
5CPA component
Consultation activity
With whom
Timeframe
Action taken in response
Supply and PBS
claiming from a
medication chart in
Residential Aged Care
Facilities
National Residential Medication Chart
Reference Group – established by the
ACSQHC

October 2011 –
ongoing










Aged Care Facility
representation
DoHA
Medicare
Consumer
Guild
AMA
ACAA
RACGP
PSA
DVA
Providing advice and guidance to the ACSQHC
on the development and implementation of the
National Residential Medication Chart project.
Department of Veterans Affairs

DVA
November 2011

Identified issues that impacted on ensuring
RPBS access is maintained and inform of
legislative amendments to the National Health
Act 1953.
Consultation regarding exemptions
required from NSW Ministry of Health

NSW Ministry of
Health
ACSQHC
July 2012 - ongoing

Provided advice to NSW Ministry of Health on
specific elements of the chart to support the
granting of the exemptions to allow the phased
implementation to commence.

Continued Dispensing
of PBS Medicines in
defined circumstances
Management of programme
implementation

ACSQHC, state
governments,
residential aged care
peak bodies, DSS.
October 2011 –
ongoing

Managed the implementation of the National
Residential Medication Chart project.
Initiative Development Meetings



Guild
DHS
PSA
August 2010 –
October 2012

Policy issues in relation to programme design,
Medicare system and implementation identified
and resolved.
Agreement on elements of the programme that
required broader consultation
Development of practice guidelines.


9
Current as at 30 June 2014
5CPA component
Continued Dispensing
of PBS Medicines in
defined circumstances
Consultation activity
With whom
Timeframe
Action taken in response
Draft content of consultation paper for
comment


PRG
AMA
November December 2010
Changes to the consult papers were made to papers
as a result of PRG advice including:

changing name of the initiative from Medication
Continuance to Continued Dispensing of PBS
Medicines in defined circumstances.

communication from pharmacists to prescribers
when a continued dispensing even has occurred
built in as a mandatory step.

indemnity issues being explored including if the
indemnity lies with the original prescriber or the
pharmacist.

the development of pharmacist education and
professional protocols.
Call for responses on parameters of
the initiative through the release of a
consultation paper


PRG
targeted aged care,
pharmacy and
prescribing industry
stakeholders
State and territory
health authorities
The general public
March – April 2011







Meetings with representatives from
state and territory departments of
health

All jurisdictions
February, August,
November,
December 2011
and March 2012.


Sought advice from PDL with regard to
pharmacy indemnity issues
Consultation on community pharmacy
software requirements
PSA – Expert Advisory Group –
industry consultation seeking
comment on professional guidelines

PDL
August 2011


MSIA








AMA
AACP
NPS
APC
PDL
CHF
Tasmanian
Department of Health
May 2011 –
December 2012
October –
November 2011
10

Responses informed legislative amendments
currently before parliament.
The Department engaged the PSA to develop
professional protocols and guidelines for
pharmacists undertaking a continued dispensing
supply.
Prior clinical review is mandatory prior to a
continued dispensing supply.
Informed issues to be addressed in relation to
implementation and change management
activities.
Released FACT SHEET at APP conference in
March 2012.
Identified and incorporated key issues into the
development and implementation of the
initiative, including informing legislative
amendments.
Provided information in relation to
Commonwealth legislative and regulatory
changes.
Advice provided will support ongoing
implementation.
Identify requirements for software vendors to
support the transition to new arrangements.
Feedback received from stakeholders has been
incorporated into the development of the
professional guidelines.
Current as at 30 June 2014
5CPA component
Electronic recording
and reporting of
controlled drugs
Electronic recording
and reporting of
controlled drugs
Consultation activity
Initiative development meetings
With whom

Guild

Medicare

PRG

AMA
Timeframe
August 2010 –
October 2010
November December 2010
Meeting with the Office of the
Australian Information Commissioner

January 2011
Call for responses on parameters of
the initiative through the release of a
public consultation paper


Office of the
Australian Information
Commissioner
PRG
Targeted health
sector stakeholders
including health
professionals and
software vendors
State and territory
health authorities
General public
Representatives of
the departments of
health in all eight
jurisdictions
Representatives of
the department of
health in all eight
jurisdictions
Draft consultation paper sent to PRG
for comment

Meetings with state and territory health
departments


State and Territory ERRCD Steering
Group

Discussions with the AMA to identify
issues for prescribers
Meetings with the Pharmacy Guild

AMA

Guild
Consultation on community pharmacy
and prescriber software requirements
Discussions with NeHTA regarding
messaging and content standards

MSIA

NeHTA
11
March 2011 –
April 2011
Action taken in response
 Determined the direction of the initiative and
drafted the public consultation paper.
 Acknowledged that the PRG was broadly
supportive of the initiative and the proposed
parameters.
 A Privacy Impact Assessment of the initiative
was conducted.


February 2011 –
August 2012

August 2012 ongoing

February and April
2012
February 2012 ongoing

February 2012 ongoing
September 2012 –
ongoing



Acknowledged that the initiative was broadly
supportive and key advice was considered and
incorporated into the development of the next
stages of the initiative, including within the High
Level requirements for the system released as a
part of the Department’s Request for Expression
of Interest 371/1011.
Released FACT SHEET on 5CPA website on
26 April 2012.
Input from the jurisdictions was used to inform
the system development and policy parameters
and implementation options for the initiative.
Input is being used to ensure that the objectives
of the initiative are achieved, risks are identified
and the initiative is implemented and operated
consistent with applicable legal and policy
obligations.
Considered options for the ‘interface’ with
practice management software.
Considered implementation options for the
development of the electronic Controlled Drugs
Register.
Identify requirements for software vendors to
support the transition to new arrangements.
Continue to liaise with NeHTA to ensure the
ERRCD system aligns with eHealth standards.
Current as at 30 June 2014
5CPA component
Pharmacy Location
Rules
Pharmacy Location
Rules
Consultation activity

Independent review conducted by
Urbis Pty Ltd, including:
- Stakeholder interviews
- Online survey
to review the effectiveness and
efficiency of the Rules

Stakeholder workshop hosted by
Department and the Guild

Meetings with the Guild

Meet with the Consumers Health
Forum staff to broadly outline the
proposed amendments to the
Rules.
With whom

Guild

DHS

RACGP

AMA

PSA

ACPA

APESMA

SPHA

PBA

CHF

NRHA

Primary Health Care

Four individual
brokers who regularly
act on behalf of
applicants

Online survey
received from 15 of
the 23 previous
applicants.

DHS

ACPA
Timeframe
January 2010 June 2010
Action taken in response

Responses informed the development of the
determination introduced into parliament.

Decision that further consultations were needed
with ACPA and DHS.
October 2010 –
October 2011



Ongoing consultation with DHS
regarding administrative processes
relevant to the Pharmacy Location
Rules

DHS
Mid 2011 – ongoing
Meetings with the Guild to discuss
proposed minor amendments to the
Pharmacy Location Rules to address
anomalies within the Rules.

Guild
Late 2012 – mid
2013
Pharmacy Location Rules Issues and
Opportunities Workshop; and
Pharmacy Location Rules Process
Discovery and Improvement
Workshop





Health (PAB and LSB)
DHS
ACPA Chair
12
April / May 2013

Development of the new location rules.
Following the registration of the determination,
stakeholders were advised of the changes via
letters to community pharmacies, agents who
act on behalf of applicants and other
stakeholders.
Frequently Asked Questions and a revised
handbook to assist potential applicants are
available on the Department’s website. Articles
were distributed to pharmacy journals for
potential inclusion in online and printed
publications.
Proposed minor amendments to address
anomalies in the Rules have been agreed.
Drafting of a new determination has
commenced.
Considering areas where application and
administrative processes could be streamlined
and possible improvements to the section 90
application process.
Current as at 30 June 2014
5CPA component
Consultation activity
With whom
Timeframe
Action taken in response
Electronic
Prescriptions
Payment processes for EPF claiming
system by DHS.




Guild
MSIA
DHS
PES vendors
June 2012 –
ongoing

DHS extends the EPF payment process to
implement an EPF payment process direct to
PES vendors and to maintain the 15 cents EPF
payment to pharmacy.
Consultations to manage Prescription
Exchange Service interoperability and
pharmacy participation in ETP



eRx and Medisecure
Guild (later)
DHS (later)
April 2012 –
ongoing

PES Interim Interoperability Initiative.
Consultation about the parameters
and definitions to apply to the Guild
proposal to pay pharmacy 15cents for
each electronic prescription dispensed


Guild
DHS
Early 2010 –
ongoing

15 cents Electronic Prescription Fee (EPF)
included in the Fifth Agreement signed on
3 May 2010.
Agreement to pay PES vendors 85 cents EPF
from 1 July 2012 to 31 Dec 2012 and 35 cents
EPS from 1 Jan 2013 to 30 June 2013.
CSO consultation workshops

CSO Funding Pool



Collection of under
co-payment data
Fifth Community
Pharmacy Agreement
Evaluation Framework
Development and implementation of
the under co-payment data collection
measure, including:

development of changes to
Medicare processes,

development of changes to
pharmacy dispensing software;

development of a communications
strategy for pharmacy;

letters providing information to
hospitals and other stakeholders;

updating of information on the
DHS and DoHA websites; and

consideration of postimplementation issues.


Ongoing stakeholder engagement to
update the Evaluation Framework
annually or as required during the Fifth
Agreement.





Pharmaceutical
wholesalers
CSO Administration
Agency
TGA
Guild
June 2010 –
October 2010
MSIA
Pharmacy software
vendors
Guild
DHS
DVA
Peak stakeholder
bodies (CHF, PSA,
SHPA, AFSPA,
APHA, RACP,
RACGP, AMA)
January 2010 –
May 2012
The Evaluation
Framework is
available on the
Department’s website
and the Department
invites public
comment from
interested
stakeholders
Ongoing
13







Changes to the CSO Service Standards and
changes to the Deeds of Agreement with CSO
Distributors.
The revised Code of Good Wholesaling Practice
is being used within the CSO framework002E.
Technical issues discussed and progressed;
Vendor resource document finalised;
Monitoring of collection of data submissions
from 1 April 2012.
Amended legislative instruments regarding the
collection of under co-payment data.
The Evaluation Framework and Department
website have been updated are based on
comments received to date.
Current as at 30 June 2014
5CPA component
Consultation activity
With whom
Timeframe
Action taken in response
Combined Review of the Medication
Management Review Programmes
under the Fifth Agreement.



PRG
Consumers
Community
Pharmacist
Accredited
Pharmacists
Hospital Pharmacists
General Practitioners
RACF residential and
nursing staff
Other Health
Professionals
July 2013 Dec 2014

PRG
Pharmacy Guild of
Australia;
Pharmacy owners;
Pharmacist workforce
(including Community
pharmacists);
Accredited
pharmacists and
relevant hospital
practitioners;
Pharmaceutical
Society of Australia;
Australian Association
of Consultant
Pharmacists;
Society of Hospital
Pharmacists of
Australia; and
Professional
Pharmacists Australia
(formerly known as
APESMA).
Consumers;
Consumers Health
Forum of Australia;
Council on the
Ageing;
Carers Australia;
National Aboriginal
Community Controlled
Health Organisation;
Mental Health Council
of Australia;
Aug 2014 –
March 2015





Combined Thematic Review of
Access, Consumer Experience and
Quality Use of Medicines under the
Fifth Agreement.















14



Advice, opinions, information and data sought
from participating stakeholders to enable
response to evaluations
Stakeholder consultation undertaken through
focus groups, interviews and surveys
Advice, opinions, information and data sought
from participating stakeholders to enable
response to evaluations
Stakeholder consultation undertaken through
focus groups, interviews, workshops and
research analysis
Current as at 30 June 2014
5CPA component
Consultation activity
With whom







Review of Governance Structures
established under the Fifth
Agreement.
















Timeframe
Action taken in response
Aug 2013 January 2015

National Rural Health
Alliance;
National Aged Care
Health Alliance;
National Prescribing
Service;
Medicines Australia;
Australian Medical
Association;
Medicare Locals
Network; and
Royal Australian
College of General
Practitioners.
ACC
PRG
Pharmacy Guild of
Australia
Pharmaceutical
Society of Australia;
Australian Association
of Consultant
Pharmacists;
Society of Hospital
Pharmacists of
Australia; and
Professional
Pharmacists Australia
(formerly known as
APESMA).
Consumers;
Consumers Health
Forum of Australia;
Council on the
Ageing;
Carers Australia;
National Aboriginal
Community Controlled
Health Organisation;
Mental Health Council
of Australia;
National Rural Health
Alliance;
National Aged Care
Health Alliance;
National Prescribing
15

Advice, opinions, information and data sought
from participating stakeholders to enable
response to evaluations
Stakeholder consultation undertaken through
interviews, surveys and workshops
Current as at 30 June 2014
5CPA component
Consultation activity
With whom










Timeframe
Action taken in response
Service;
Medicines Australia;
Australian Medical
Association;
Medicare Locals
Network; and
Royal Australian
College of General
Practitioners.
Generic Medicines
Industry Association
National Australian
Pharmacy Students'
Association (NAPSA)
Department of Health
Department of Human
Services(Medicare)
Department of
Veteran Affairs
State and Territory
Health Departments
16
Current as at 30 June 2014